                         SEQUENCE LISTING

<110>  NaniRx, Inc.
       Cohen, David I.
 
<120>  Treatment of Cancers with Immunostimulatory HIV Tat derivative 
       polypeptides

<130>  1951311-00015

<150>  61/162,605
<151>  2009-03-23

<150>  61/306,278
<151>  2010-02-19

<150>  61/310,221
<151>  2010-03-03

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  101
<212>  PRT
<213>  Human immunodeficiency virus

<400>  1

Met Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys Lys Cys Cys Phe 
            20                  25                  30          


His Cys Gln Val Cys Phe Thr Lys Lys Ala Leu Gly Ile Ser Tyr Gly 
        35                  40                  45              


Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Glu Asp Ser Gln Thr 
    50                  55                  60                  


His Gln Val Ser Pro Pro Lys Gln Pro Ala Pro Gln Phe Arg Gly Asp 
65                  70                  75                  80  


Pro Thr Gly Pro Lys Glu Ser Lys Lys Lys Val Glu Arg Glu Thr Glu 
                85                  90                  95      


Thr His Pro Val Asp 
            100     


<210>  2
<211>  102
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Nani-P1 modified HIV Tat sequence

<400>  2

Met Glu Pro Val Asp Ala Asn Leu Glu Ala Trp Lys His Ala Gly Ser 
1               5                   10                  15      


Gln Pro Arg Lys Thr Ala Cys Thr Thr Cys Tyr Cys Lys Lys Cys Cys 
            20                  25                  30          


Phe His Cys Gln Val Cys Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr 
        35                  40                  45              


Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln 
    50                  55                  60                  


Thr His Gln Ala Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg Gly 
65                  70                  75                  80  


Asp Pro Thr Gly Pro Thr Glu Ser Lys Lys Lys Val Glu Arg Glu Thr 
                85                  90                  95      


Glu Thr Asp Pro Phe Asp 
            100         


<210>  3
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Nani-P2 modified HIV Tat sequence

<400>  3

Met Asp Pro Lys Gly Glu Glu Asp Gln Asp Val Ser His Gln Asp Leu 
1               5                   10                  15      


Ile Lys Gln Tyr Arg Lys Pro Arg Thr Ala Cys Asn Asn Cys Tyr Cys 
            20                  25                  30          


Lys Lys Cys Cys Phe His Cys Tyr Ala Cys Phe Leu Arg Lys Gly Leu 
        35                  40                  45              


Gly Ile Thr Tyr His Ala Phe Arg Thr Arg Arg Lys Lys Ile Ala Ser 
    50                  55                  60                  


Ala Asp Arg Ile Pro Val Pro Gln Gln Ser Ile Ser Ile Arg Gly Arg 
65                  70                  75                  80  


Asp Ser Gln Thr Thr Gln Glu Ser Gln Lys Lys Val Glu Glu Gln Ala 
                85                  90                  95      


Lys Ala Asn Leu Arg Ile Ser Arg Lys Asn Leu Gly Asp Glu Thr Arg 
            100                 105                 110         


Gly Pro Val Gly Ala Gly Asn 
        115                 


<210>  4
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Nani-P3 modified HIV Tat sequence

<400>  4

Met Glu Thr Pro Leu Lys Glu Gln Glu Asn Ser Leu Glu Ser Cys Arg 
1               5                   10                  15      


Glu His Ser Ser Ser Ile Ser Glu Val Asp Val Pro Thr Pro Val Ser 
            20                  25                  30          


Cys Leu Arg Lys Gly Gly Arg Cys Trp Asn Arg Cys Ile Gly Asn Thr 
        35                  40                  45              


Arg Gln Ile Gly Ser Cys Gly Val Pro Phe Leu Lys Cys Cys Lys Arg 
    50                  55                  60                  


Lys Pro Phe Thr Arg Lys Gly Leu Gly Ile Ser Tyr Gly Arg Lys Lys 
65                  70                  75                  80  


Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln Thr His Gln Ala 
                85                  90                  95      


Ser Leu Ser Lys Gln Pro Ala Ser Gln Ser Arg Gly Asp Pro Thr Gly 
            100                 105                 110         


Pro Thr Glu Ser Lys Lys Lys Val Glu Arg Glu Thr Glu Thr Asp Pro 
        115                 120                 125             


Phe Asp 
    130 


